Editor’s note. Alliance Defending Freedom responded yesterday to the opening briefs the U.S. Department of Justice and Danco Laboratories filed Tuesday with the U.S. Supreme Court in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine. “Women and...
Communications Department
202.626.8825
mediarelations@nrlc.org
Press Room News / FDA

Missouri Sues FDA For Allowing Abortion Pills To Be Shipped Via Mail
By Katelynn Richardson Missouri Attorney General Andrew Bailey announced Monday that several states sued the U.S. Food and Drug Administration (FDA) for allowing abortion pills to be shipped through the mail. Missouri, along with Idaho and Kansas, filed...

Alliance for Hippocratic Medicine vs. FDA: A Quick Run-Down
By Virginia Pride, Secular Pro-Life Earlier in 2023, the Alliance for Hippocratic Medicine [AHM], other pro-life medical organizations, and individual pro-life physicians filed a federal district court in Dallas, against the FDA concerning their regulations on...
FDA sends warning letters to two entities selling mislabeled and unapproved abortion drugs over the Internet
By Dave Andrusko On Monday, the FDA sent warning letters to two online entities for introducing “Misbranded and Unapproved New Drugs into Interstate Commerce,” specifically mifepristone and misoprostol, the two drugs that make up the “RU-486”abortion technique....
Texas Planned Parenthood says 4-fold increase in chemical abortions since FDA relaxed protocol
By Dave Andrusko Editor’s note. If you want to peruse stories all day long, go directly to nationalrighttolifenews.org and/or follow me on Twitter at twitter.com/daveha Since pro-lifers have no insiders inside the Guttmacher Institute, we can only speculate why it...
Members of House and Senate ask for documents behind FDA change in FDA protocol
By Dave Andrusko If you click here, you can read the entire letter sent by Rep. Chris Smith (R-NJ) and Senator James Lankford (R-OK), joined by 73 of their colleagues, to Dr. Robert M. Califf, M.D., the FDA’s Commissioner, “requesting information about the agency’s...
In letter Members of House and Senate voice deep disappointment that FDA loosened standards for use of RU-486
Editor’s note. The following letter was sent to the Commissioner of the FDA by Rep. Chris Smith (R-NJ) and Senator James Lankford (R-OK), joined by 73 of their colleagues. April 25, 2016 Dr. Robert M. Califf, M.D. Commissioner Food and Drug Administration (FDA) 10903...
Cardinal Dolan Calls New FDA Abortion Drug Guidelines ‘Irresponsible,’ Offers Assistance to Pregnant Women
WASHINGTON--Cardinal Timothy Dolan, archbishop of New York and chair of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities responded to new guidelines issued by the Food and Drug Administration (FDA) for the abortion drug, RU-486. "The FDA has...
Unanswered questions in light of FDA changing its RU-486 protocol
By Dave Andrusko There was so much coverage yesterday of Donald Trump’s comment about “punishing” women who have aborted (a position he later reversed) that perhaps not enough attention was paid to the gift the FDA gave to the Abortion Industry in general, Planned...
FDA greases the skids for greater use of chemical abortions
By Dave Andrusko Dr. Randall K. O’Bannon, Ph.D., NRL Director of Education & Research, knows as much as anyone in the pro-life community about the two-drug abortion technique, RU-486. That’s why before you read these remarks, please read his story responding the...